Comparison of visual evoked potentials and retinal nerve fiber layer thickness in Alzheimer's disease

Frontiers in Neurology

Volumn 4 DEC, Issue , 2013, Pages

  Kromer, Robert ^a   Serbecic, Nermin ^a   Hausner, Lucrezia ^a   Froelich, Lutz ^a   Beutelspacher, Sven C ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alzheimer's disease; Dementia; Optical coherence tomography; Retinal nerve fiber layer thickness; Visual evoked potentials

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EVOKED VISUAL RESPONSE; EYE TRACKING; FEMALE; HUMAN; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; PERIMETRY; REPRODUCIBILITY; RETINAL NERVE FIBER LAYER THICKNESS; SEX DIFFERENCE; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VERY ELDERLY; VISUAL ACUITY;

EID: 84891654249     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00203     Document Type: Article

References (52)

1. Guo L, Salt TE, Maass A, Luong V, Moss SE, Fitzke FW, et al. Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. Invest Ophthalmol Vis Sci (2006) 47:626-33. doi: 10.1167/iovs.05-0754.
2. Jagust WJ, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M. Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann Neurol (2006) 59:673-81. doi:10.1002/ana.20799.
3. Davatzikos C, Resnick SM, Wu X, Parmpi P, Clark CM. Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. Neuroimage (2008) 41:1220-7. doi:10.1016/j.neuroimage.2008.03.050.
4. Jagust WJ, Seab JP, Huesman RH, Valk PE, Mathis CA, Reed BR, et al. Diminished glucose transport in Alzheimer's disease: dynamic PET studies. J Cereb Blood Flow Metab (1991) 11:323-30. doi:10.1038/jcbfm.1991.65.
5. Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, et al. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain (2006) 129:2856-66. doi:10.1093/brain/awl178.
6. Barrio JR, Kepe V, Satyamurthy N, Huang SC, Small G. Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment. J Nutr Health Aging (2008) 12:61S-5S. doi:10.1007/BF02982589.
7. Bouwman FH, Schoonenboom NSM, Verwey NA, van Elk EJ, Kok A, Blankenstein MA, et al. CSF biomarker levels in early and late onsetalzheimer's disease. Neurobiol Aging (2009) 30:1895-901. doi:10.1016/j.neurobiolaging.2008.02.007.
8. Diniz BSO, Pinto Júnior JA, Forlenza OV. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry (2008) 9:172-82. doi:10.1080/15622970701535502.
9. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet (2011) 377:1019-31. doi:10.1016/S0140-6736(10)61349-9.
10. Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett (2007) 420:97-9. doi:10.1016/j.neulet.2007.02.090.
11. Iseri P, Altinas O, Tokay T, Yuksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuro-Ophthalmol (2006) 26:18-24. doi:10.1097/01.wno.0000204645.56873.26.
12. Kesler A, Vakhapova V, Korczyn AD, Naftaliev E, Neudorfer M. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg (2011) 113:523-6. doi:10.1016/j.clineuro.2011.02.014.
13. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science (1991) 254:1178-81. doi:10.1126/science.1957169.
14. Schuman JS, Pedut-Kloizman T, Pakter HM, Wang N, Guedes V, Huang L, et al. Optical coherence tomography and histologic measurements of nerve fiber layer thickness in normal and glaucomatous monkey eyes. Invest Ophthalmol Vis Sci (2007) 48:3645-54. doi:10.1167/iovs.06-0876.
15. Guedes V, Schuman JS, Hertzmark E, Wollstein G, Correnti A, Mancini R, et al. Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmology (2003) 110:177-89. doi:10.1016/S0161-6420(02)01564-6.
16. Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP, et al. Optical coherence tomography of the human retina. Arch Ophthalmol (1995) 113:325-32. doi:10.1001/archopht.1995.01100030081025.
17. Hee MR, Puliafito CA, Wong C, Duker JS, Reichel E, Schuman JS, et al. Optical coherence tomography of macular holes. Ophthalmology (1995) 102:748-56. doi:10.1016/S0161-6420(95)30959-1.
18. Krivoy D, Gentile R, Liebmann J, Stegman Z, Walsh J, Ritch R. Imaging congenital optic disc pits and associated maculopathy using optical coherence tomography. Arch Ophthalmol (1996) 114:165-70. doi:10.1001/archopht.1996.01100130159008.
19. Serbecic N, Beutelspacher SC, Kircher K, Reitner A, Schmidt-Erfurth U. Interpretation of RNFLT values in multiple sclerosis-associated acute optic neuritis using high-resolution SD-OCT device. Acta Ophthalmol (2012) 90(6):540-5. doi:10.1111/j.1755-3768.2010.02013.x.
20. Serbecic N, Aboul-Enein FC, Beutelspacher SC, Graf M, Kircher K, Geitzenauer W, et al. Heterogeneous pattern of retinal nerve fiber layer in multiple sclerosis. High resolution optical coherence tomography: potential and limitations. PLoS One (2010) 5:e13877. doi:10.1371/journal.pone.0013877.
21. Serbecic N, Beutelspacher SC, Aboul-Enein FC, Kircher K, Reitner A, Schmidt-Erfurth U. Reproducibility of high-resolution optical coherence tomography measurements of the nerve fibre layer with the new Heidelberg Spectralis optical coherence tomography. Br J Ophthalmol (2011) 95:804-10. doi:10.1136/bjo.2010.186221.
22. Serbecic N, Aboul-Enein FC, Beutelspacher SC, Vass C, Kristoferitsch W, Lassmann H, et al. High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years. PLoS One (2011) 6:e19843. doi:10.1371/journal.pone.0019843.
23. Curcio CA, Drucker DN. Retinal ganglion cells in Alzheimer's disease and aging. Ann Neurol (1993) 33:248-57. doi:10.1002/ana.410330305.
24. Davies DC, McCoubrie P, McDonald B, Jobst KA. Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease. Br J Ophthalmol (1995) 79:596-600. doi:10.1136/bjo.79.6.596.
25. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci (2007) 48:2285-9. doi:10.1167/iovs.06-1029.
26. Hedges TR, Perez Galves R, Speigelman D, Barbas NR, Peli E, Yardley CJ. Retinal nerve fiber layer abnormalities in Alzheimer's disease. Acta Ophthalmol Scan (1996) 74:271-5. doi:10.1111/j.1600-0420.1996.tb00090.x.
27. Valenti DA. Neuroimaging of retinal nerve fiber layer in AD using optical coherence tomography. Neurology (2007) 69:1060. doi:10.1212/01.wnl.0000280584.64363.83.
28. Sokol S. An electrodiagnostic index of macular degeneration. Use of a checkerboard pattern stimulus. Arch Ophthalmol (1972) 88:619-24.
29. Halliday AM, McDonald WI, Mushin J. Visual evoked response in diagnosis of multiple sclerosis. Br Med J (1973) 4:661-4. doi:10.1136/bmj.4.5893.661.
30. Arden GB. Proceedings: the visual evoked response in ophthalmology. Proc R Soc Med (1973) 66:1037-43.
31. Bodis-Wollner I, Atkin A, Raab E, Wolkstein M. Visual association cortex and vision in man: pattern-evoked occipital potentials in a blind boy. Science (1977) 198:629-31. doi:10.1126/science.918658.
32. Harding GF, Wright CE, Orwin A. Primary presenile-dementia-the use of the visual evoked-potential as a diagnostic indicator. Br J Psychiatry (1985) 147:532-9. doi:10.1192/bjp.147.5.532.
33. Orwin A, Wright CE, Harding GF, Rowan DC, Rolfe EB. Serial visual evoked potential recordings in Alzheimer's disease. Br Med J (Clin Res Ed) (1986) 293:9-10. doi:10.1136/bmj.293.6538.9.
34. Pollock VE, Schneider LS, Chui HC, Henderson V, Zemansky M, Sloane RB. Visual evoked-potentials in dementia-a meta-analysis and empirical-study of Alzheimers-disease patients. Biol Psychiat (1989) 25:1003-13. doi:10.1016/0006-3223(89)90288-6.
35. Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Tormene AP, et al. ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol (2010) 120:111-9. doi:10.1007/s10633-009-9195-4.
36. Beutelspacher SC, Serbecic N, Hausner L, Kromer R, Aboul-Enein FC, Froehlich L, et al. Detection of retinal nerve fibre layer defects in Alzheimers dementia using SD-OCT. Acta Ophthalmol (2011) 89:0-0. doi:10.1111/j.1755-3768.2011.2262.x.
37. Coben LA, Danziger WL, Hughes CP. Visual evoked potentials in mild senile dementia of Alzheimer type. Electroencephalogr Clin Neurophysiol (1983) 55:121-30. doi:10.1016/0013-4694(83)90178-5.
38. Visser SL, van Tilburg W, Hooijer C, Jonker C, de Rijke W. Visual evoked potentials (VEPs) in senile dementia (Alzheimer type) and in non-organic behavioural disorders in the elderly; comparison with EEG parameters. Electroencephalogr Clin Neurophysiol (1985) 60:115-21. doi:10.1016/0013-4694(85)90017-3.
39. Bajalan AA, Wright CE, van der Vliet VJ. Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease. J Neurol Neurosurg Psychiatr (1986) 49:175-82. doi:10.1136/jnnp.49.2.175.
40. Cosi V, Vitelli E, Gozzoli L, Corona A, Ceroni M, Callieco R. Visual evoked potentials in aging of the brain. Adv Neurol (1982) 32:109-15.
41. Wright CE, Drasdo N, Harding GF. Pathology of the optic nerve and visual association areas. Information given by the flash and pattern visual evoked potential, and the temporal and spatial contrast sensitivity function. Brain (1987) 110(Pt 1):107-20. doi:10.1093/brain/110.1.107.
42. Wright CE, Harding GF, Orwin A. Presenile dementia-the use of the flash and pattern VEP in diagnosis. Electroencephalogr Clin Neurophysiol (1984) 57:405-15. doi:10.1016/0013-4694(84)90069-5.
43. Wright CE, Harding GF, Orwin A. The flash and pattern VEP as a diagnostic indicator of dementia. Doc Ophthalmol (1986) 62:89-96. doi:10.1007/BF00140551.
44. Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med (1986) 315:485-7. doi:10.1056/NEJM198608213150804.
45. Sadun AA, Bassi CJ. Optic nerve damage in Alzheimer's disease. Ophthalmology (1990) 97:9-17. doi:10.1016/S0161-6420(90)32621-0.
46. Tsai CS, Ritch R, Schwartz B, Lee SS, Miller NR, CHI T, et al. Optic-nerve head and nerve-fiber layer in Alzheimer's-disease. Arch Ophthalmol (1991) 109:199-204. doi:10.1001/archopht.1991.01080020045040.
47. Blanks JC, Torigoe Y, Hinton DR, Blanks RH. Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging (1996) 17:377-84. doi:10.1016/0197-4580(96)00010-3.
48. Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH. Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging (1996) 17:385-95. doi:10.1016/0197-4580(96)00010-3.
49. Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol (2001) 112:1860-7. doi:10.1016/S1388-2457(01)00620-4.
50. Parisi V. Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer's disease. Semin Ophthalmol (2003) 18:50-7. doi:10.1080/08820530390897855.
51. Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R, et al. Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography. Neurosci Lett (2010) 480:69-72. doi:10.1016/j.neulet.2010.06.006.
52. Tasman W. Duane's Ophthalmology 2012. Philadelphia: Lippincott Williams & Wilkins (2012).